Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biomx Ltd (NY: PHGE ) 1.020 -0.035 (-3.32%) Official Closing Price Updated: 8:00 PM EDT, Sep 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Biomx Ltd Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers May 31, 2024 Via AB Newswire Exposures Product Safety BiomX To Present at H.C. Wainwright 24th Annual Global Investment Conference September 11, 2022 From BiomX Inc. Via Business Wire BiomX Reports Second Quarter 2022 Financial Results and Provides Business Update August 10, 2022 From BiomX Inc. Via Business Wire BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022 August 07, 2022 From BiomX Inc. Via Business Wire BiomX Announces Publication in Cell of Research Demonstrating Proof-of-Concept Assessment of Orally Administered Phage Treatment in Preclinical Model of Inflammatory Bowel Disease August 04, 2022 From BiomX Via Business Wire BiomX Announces Voluntary Delisting from the Tel Aviv Stock Exchange July 06, 2022 From BiomX Inc. Via Business Wire Boehringer Ingelheim and BiomX Collaborate to Discover Inflammatory Bowel Disease Microbiome Biomarkers June 28, 2022 From BiomX Inc. Via Business Wire BiomX Announces Dosing of the First Two Patients in Phase 1b/2a Study of BX004 for Treatment of Chronic Respiratory Infections in Patients with Cystic Fibrosis June 27, 2022 From BiomX Inc. Via Business Wire BiomX Announces Corporate Restructuring May 24, 2022 From BiomX Inc. Via Business Wire BiomX Announces Publication in the Journal, Bioinformatics May 20, 2022 From BiomX Inc. Via Business Wire BiomX Reports First Quarter 2022 Financial Results and Provides Business Update May 11, 2022 From BiomX Inc. Via Business Wire BiomX to Host Key Opinion Leader Event on BX004 for Treatment of Pseudomonas Aeruginosa Infections in Cystic Fibrosis Patients May 06, 2022 From BiomX Inc. Via Business Wire BiomX to Host First Quarter 2022 Financial Results Conference Call and Webcast on May 11, 2022 May 05, 2022 From BiomX Inc. Via Business Wire BiomX Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update March 30, 2022 From BiomX Inc. Via Business Wire BiomX to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast on March 30, 2022 March 23, 2022 From BiomX Inc. Via Business Wire BiomX Presenting at Three Upcoming Investor Conferences February 24, 2022 From BiomX Inc. Via Business Wire BiomX Announces Therapeutics Development Award of up to $5 Million from the Cystic Fibrosis Foundation January 04, 2022 From BiomX Inc. Via Business Wire BiomX Presents Preclinical Results With BX005 for Atopic Dermatitis at the Revolutionizing Atopic Dermatitis 2021 Virtual Conference and the International Conference on Phage Therapy and Bacteriophages June 14, 2021 From BiomX Inc. Via Business Wire BiomX to Present Preclinical Results with BX004 in Cystic Fibrosis at the 44th European Cystic Fibrosis Conference June 09, 2021 From BiomX Inc. Via Business Wire BiomX Reports First Quarter 2021 Financial Results and Provides Business Updates May 24, 2021 From BiomX Inc. Via Business Wire BiomX to Host First Quarter 2021 Financial Results Conference Call and Webcast on May 24, 2021 May 18, 2021 From BiomX Inc. Via Business Wire BiomX to Present at Upcoming April Investor Events April 20, 2021 From BiomX Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.